Lorenzo A Pinna

发表

Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.

Paolo Bonvini, S. Moro, L. Pinna, 2006, Journal of medicinal chemistry.

Phosphorylation of calmodulin fragments by protein kinase CK2. Mechanistic aspects and structural consequences.

L. Pinna, G. Arrigoni, L. Settimo, 2004, Biochemistry.

Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase*

Carlo Gambacorti-Passerini, Leonardo Scapozza, L. Scapozza, 2008, Journal of Biological Chemistry.

Roscovitine Targets, Protein Kinases and Pyridoxal Kinase*[boxs]

Lin Tang, Hervé Galons, Olivier Lozach, 2005, Journal of Biological Chemistry.

Functional homology between yeast piD261/Bud32 and human PRPK: both phosphorylate p53 and PRPK partially complements piD261/Bud32 deficiency

G. Carignani, M. Montenarh, C. Götz, 2003, FEBS letters.

CK2 regulates in vitro the activity of the yeast cyclin-dependent kinase inhibitor Sic1.

Matteo Barberis, Lilia Alberghina, Marco Vanoni, 2005, Biochemical and biophysical research communications.

Conformational constraints of tyrosine in protein tyrosine kinase substrates: Information about preferred bioactive side‐chain orientation

Andrea Guiotto, P. Ruzza, L. Cesaro, 2003, Biopolymers.

The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.

E. Itarte, L. Pinna, J. Vilardell, 2008, Biochemistry.

Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.

Roberto Battistutta, L. Pinna, R. Battistutta, 2011, Biochemistry.

From phosphoproteins to phosphoproteomes: a historical account

Andrea Venerando, A. Venerando, L. Cesaro, 2017, The FEBS journal.

Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.

Alessandra Gianoncelli, Andrea Venerando, S. Moro, 2008, Bioorganic & medicinal chemistry letters.

Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.

Giuseppe Zanotti, Roberto Battistutta, L. Pinna, 2005, Chemistry & biology.